33
Participants
Start Date
April 19, 2005
Primary Completion Date
April 5, 2010
Study Completion Date
May 17, 2013
lenalidomide
10 mg daily orally administered on days 1 - 21 followed by 7 days rest of a 28-day cycle, increasing dose by 5 mg every cycle, up to a maximum of 25 mg.
Stanford Cancer Center, Stanford
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
M. D. Anderson Cancer Center at University of Texas, Houston
National Cancer Institute (NCI)
NIH
Northwestern University
OTHER